Free Trial
→ Blackrock’s Sending THIS Crypto Higher on Purpose (From Crypto 101 Media) (Ad) Buy KURA Stock  Free KURA Stock Alerts

Kura Oncology (KURA) SEC Filings & 10K Form

Kura Oncology logo
$6.47 -0.02 (-0.31%)
Closing price 04:00 PM Eastern
Extended Trading
$6.46 0.00 (-0.08%)
As of 06:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Kura Oncology SEC Filings

Export to Excel
DateFilerForm TypeView
05/01/2025
3:10 PM		Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
3:15 PM		Kura Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/17/2025
4:00 PM		Kura Oncology (Filer)
Form ARS
03/24/2025
3:33 PM		Hasnain Faheem (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
3:21 PM		Hasnain Faheem (Reporting)
Kura Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
4:30 PM		ARMISTICE CAPITAL, LLC (Filed by)
Kura Oncology (Subject)
Form SCHEDULE 13G
02/14/2025
3:42 PM		Kura Oncology (Subject)
Paradigm Biocapital Advisors LP (Filed by)
Form SCHEDULE 13G/A
02/13/2025
7:15 PM		Kura Oncology (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SCHEDULE 13G/A
02/13/2025
7:57 AM		Flynn James E (Filed by)
Kura Oncology (Subject)
Form SCHEDULE 13G/A
02/04/2025
7:05 PM		BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
Form SCHEDULE 13G/A
02/04/2025
7:09 PM		BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
Form SCHEDULE 13G
01/28/2025
7:54 PM		DOYLE THOMAS JAMES (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:36 PM		Kura Oncology (Subject)
Powl Brian T. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
7:37 PM		Burrows Francis (Reporting)
Kura Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
7:37 PM		DOYLE THOMAS JAMES (Reporting)
Kura Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
7:37 PM		FORD KATHLEEN (Reporting)
Kura Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
7:37 PM		Bair Teresa Brophy (Reporting)
Kura Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
7:37 PM		Kura Oncology (Subject)
Leoni Mollie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
7:38 PM		Kura Oncology (Issuer)
Powl Brian T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:38 PM		Burrows Francis (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:38 PM		FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:38 PM		Bair Teresa Brophy (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:39 PM		Kura Oncology (Issuer)
Leoni Mollie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:36 PM		Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
6:42 PM		BlackRock, Inc. (Filed by)
Kura Oncology (Subject)
Form SCHEDULE 13G
01/07/2025
4:48 PM		Kura Oncology (Issuer)
Leoni Mollie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:42 PM		Kura Oncology (Issuer)
Leoni Mollie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
4:25 PM		Burrows Francis (Reporting)
Kura Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
4:32 PM		Burrows Francis (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:35 PM		Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
5:55 PM		Kura Oncology (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
11/20/2024
4:21 PM		Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:32 PM		BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
06/07/2024
3:30 PM		Collins Helen Louise (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM		Hasnain Faheem (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM		Kura Oncology (Issuer)
Malley Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM		Kura Oncology (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM		Kura Oncology (Issuer)
Parks Diane L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM		Kura Oncology (Issuer)
Szela Mary T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM		Kura Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/24/2024
3:06 PM		Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump Orders 'National Digital Asset Stockpile' (Ad)

Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what could be the biggest wealth opportunity since Bitcoin's early days.

Click Here to get our complete analysis on why this lending platform is our #1 "buy the dip" opportu
05/20/2024
5:30 PM		Bair Teresa Brophy (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
3:19 PM		Bair Teresa Brophy (Reporting)
Kura Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
3:34 PM		Kura Oncology (Subject)
Paradigm Biocapital Advisors LP (Filed by)
Form SC 13G
05/02/2024
3:15 PM		Kura Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:KURA) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsored
Trump Orders 'National Digital Asset Stockpile'
Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...
Crypto 101 Media | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored